omniture
LUMOSA THERAPEUTICS

Latest News

Lumosa Therapeutics and CHI Memorial announce new study for acute stroke

TAIPEI and CHATTANOOGA, Tenn., Feb. 2, 2024 /PRNewswire/ -- Lumosa Therapeutics (Lumosa; 6535.TWO),...

2024-02-02 22:22 2921

Lumosa Therapeutics Announces Positive Results from LT3001 Phase 2a Clinical Trial in Acute Ischemic Stroke

* LT3001 met primary safety endpoint. No symptomatic intracranial hemorrhage occurred. * LT3001...

2021-08-03 22:48 1922

LT1001 (Naldebain(R)), an Extended-Release Analgesic Injection, Received Its Second Approval from Singapore's HSA

TAIPEI, Dec. 21, 2020 /PRNewswire/ -- Lumosa Therapeutics is pleased to announce the market approva...

2020-12-21 22:08 2039